4th Quarter - Report

ALSTON & BIRD LLP for NOVO NORDISK INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Transatlantic Trade and Investment Partnership (TTIP) as it relates to intellectual property.

LobbyistCovered position, as disclosed
MARK RAYDER —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

H.R. 8, the American Taxpayer Relief Act (R&D tax credit) of 2012; H.R. 2052 and S. 1023, the Global Investment in American Jobs Act of 2013; corporate tax inversions.

LobbyistCovered position, as disclosed
MARK RAYDER —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2052 (113th), H.R. 8 (113th), S. 1023 (113th)

Health Issues HCR

National Diabetes Prevention Program; Better care and treatment of people with diabetes under Pub. L. 111-148, the Patient Protection and Affordable Care Act of 2009 (ACA) and Pub. L. 111-152, the Health Care and Education Affordability Reconciliation Act of 2010; Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting ("Catalyst for Better Diabetes"); H.R. 1074 and S. 539, the National Diabetes Clinical Care Commission Act of 2013; H.R. 8, the American Taxpayer Relief Act(Special Diabetes Program reauthorization); H.R. 351 and S. 351, the Protecting Seniors'Access to Medicare Act of 2013 (IPAB repeal); Diabetes screening recommendations under USPSTF.

LobbyistCovered position, as disclosed
JOYCE E GRESKO —
ELINOR HILLER —
CAITLIN MALONEY —
MARK RAYDER —
COLIN ROSKEY —
REGINA MARIA SHERICK —
ROBERT SIGGINS —
MARILYN K YAGER —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 8 (113th), H.R. 351 (113th), S. 351 (113th), S. 539 (113th), H.R. 1074 (113th)

Medicare/Medicaid MMM

H.R. 962 and S. 452, the Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in Pub. L. 112-25, the Budget Control Act of 2011 and H.R. 8, the American Taxpayer Relief Act of 2012; H.R. 1588 and S. 740, the Medicare Drug Savings Act of 2013; H.R. 1257, the Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S. 945, the Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare); Medicare diabetes screening generally; diabetes screening recommendations under USPSTF.

LobbyistCovered position, as disclosed
JOYCE E GRESKO —
CAITLIN MALONEY —
MARK RAYDER —
COLIN ROSKEY —
REGINA MARIA SHERICK —
ROBERT SIGGINS —
MARILYN K YAGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: S. 452 (113th), H.R. 1588 (113th), S. 740 (113th), H.R. 1274 (113th), H.R. 962 (113th), S. 945 (113th), H.R. 8 (113th), H.R. 1257 (113th)

Budget/Appropriations BUD

H.R. 2663 and S. 1422, the Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program); P.L. 113-235, the Consolidated and Further Continuing Appropriations Act, 2015.

LobbyistCovered position, as disclosed
MARK RAYDER —
REGINA MARIA SHERICK —
ROBERT SIGGINS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR)

Bills named: S. 1422 (113th), H.R. 2663 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.